Abstract

Another big drug firm is joining the mRNA therapy field. Pfizer is paying BioNTech $120 million to develop mRNA flu vaccines and offering up to $305 million more in potential milestone payments. Mo...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call